Acid-inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects - a randomised open-label cross-over study
Author:
Affiliation:
1. Takeda Pharmaceutical Company Ltd.; Osaka Japan
2. Medical Co. LTA Hakata Clinic; Fukuoka Japan
Funder
Takeda Pharmaceutical Company
Publisher
Wiley
Subject
Pharmacology (medical),Gastroenterology,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.13325/fullpdf
Reference27 articles.
1. Critical effect of Helicobacter pylori infection on the effectiveness of omeprazole for prevention of gastric or duodenal ulcers among chronic NSAID users;Graham;Helicobacter,2002
2. Effective intra-oesophageal acid suppression in patients with gastro-oesophageal reflux disease: lansoprazole vs. pantoprazole;Frazzoni;Aliment Pharmacol Ther,2003
3. Proton pump inhibitors: update on their role in acid-related gastrointestinal diseases;Robinson;Int J Clin Pract,2005
4. Helicobacter pylori eradication is beneficial in the treatment of functional dyspepsia;Malfertheiner;Aliment Pharmacol Ther,2003
5. Review article: the control of gastric acid and Helicobacter pylori eradication;Sachs;Aliment Pharmacol Ther,2000
Cited by 288 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy and safety of vonoprazan versus proton pump inhibitors in the treatment of peptic ulcer disease: a systematic review and network meta-analysis for randomized controlled trails;Frontiers in Nutrition;2024-09-05
2. Comparison of Vonoprazan Versus Intravenous Proton Pump Inhibitor for Prevention of High-Risk Peptic Ulcers Rebleeding After Successful Endoscopic Hemostasis: A Multicenter Randomized Noninferiority Trial;Gastroenterology;2024-09
3. AGA Clinical Practice Update on Integrating Potassium-Competitive Acid Blockers Into Clinical Practice: Expert Review;Gastroenterology;2024-09
4. Vonoprazan Dual or Triple Therapy Versus Bismuth‐Quadruple Therapy as First‐Line Therapy for Helicobacter pylori Infection: A Three‐Arm, Randomized Clinical Trial;Helicobacter;2024-09
5. Safety of potassium-competitive acid blockers in the treatment of gastroesophageal reflux disease;Expert Opinion on Drug Metabolism & Toxicology;2024-08-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3